Transcription of Model Standing Order and Immunization Protocol Template
{{id}} {{{paragraph}}}
Example: stock market
Model Standing Order and Immunization Protocol Template
IP COVID-19 Vaccine Page 1 of 19 OHA 8285 (7/19) A. PUBLIC HEALTH DIVISION Immunization Program Immunization Protocol COVID-19 Vaccine (Pfizer-BioNTech, Moderna, Janssen [Johnson & Johnson]) Last Reviewed 7 January 2022 Last Revised 7 January 2022 This Order expires 30 June 2022 Table of contents What s new .. 1 Oregon Immunization Protocol .. 2 Vaccine schedule for COVID-19 Vaccine .. 3 Licensed COVID-19 vaccine .. 4 Recommendations for use .. 5 Contraindications .. 6 Warnings and precautions .. 7 Other considerations .. 8 Side effects and adverse reactions .. 9 Storage and handling .. 9 Adverse events reporting .. 11 References .. 12 Appendix A .. 15 Appendix B .. 16 Appendix C .. 17 Appendix D .. 19 What s new CDC now recommends that all people 12 years of age receive a booster dose of Pfizer vaccine 5 months after completing their initial Pfizer vaccination The interval between the final dose in the primary series and the booster dose has been shortened to 5 months for the Moderna IP COVID-19 Vaccine Page 2 of 19 Immunocompromised children 5 through 11 years old should receive a third dose of Pfizer vaccine 28 days after the previo
The 1- or 2-dose series of a mRNA COVID-19 vaccine should be offered to all persons aged 18 years and older. Additionally, Pfizer COVID-19 vaccine should be offered to all persons aged 5 years through 17 years of age. 14. B. Children who turn 12 years of age after their first dose of Pfizer vaccine may be
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: